Pricing Log in Create free account

Oramed Pharmaceuticals Inc. (ORMP) vs Zentalis Pharmaceuticals, Inc. (ZNTL)

Oramed Pharmaceuticals Inc. and Zentalis Pharmaceuticals, Inc. are both Biotechnology companies. Oramed Pharmaceuticals Inc. and Zentalis Pharmaceuticals, Inc. are of similar size ($171.8M and $166.6M). Zentalis Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Oramed Pharmaceuticals Inc. trades at 0.9×. Across the 10 metrics below, Oramed Pharmaceuticals Inc. leads on 8 and Zentalis Pharmaceuticals, Inc. on 2.

Valuation

Metric ORMP ZNTL Biotechnology median
P/E 0.93 n/m 10.26
P/S 40.01 n/m 9.18
P/B 0.51 0.85 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.34 0.65
EV/Sales 27.42 n/m 8.98
Earnings yield 107.91% (114.04%) (34.89%)
Free cash flow yield (3.24%) (104.95%) (24.52%)

Profitability

Metric ORMP ZNTL Biotechnology median
Gross margin 32.31% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 73.90% (66.75%) (50.12%)
Return on assets 65.52% (49.22%) (45.60%)
Return on invested capital (3.40%) 0.00% 0.00%

Growth

Metric ORMP ZNTL Biotechnology median
Revenue growth (TTM) 48.76% — 6.26%
EPS growth (last fiscal year) 412.50% 18.03% 29.88%
Revenue growth, 5-year CAGR (5.85%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ORMP ZNTL Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.98 4.82 4.89
Net debt to EBITDA 8.41 1.59 1.01

Dividend

Metric ORMP ZNTL Biotechnology median
Dividend yield 6.38% — 0.41%
Payout ratio 0.06 — —

Size

Metric ORMP ZNTL Biotechnology median
Market cap 171.80m 166.63m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack